跳至主要内容
临床试验/NCT04939155
NCT04939155Unknown不适用

Measuring the DNA Methylation Effects From COVID-19 Infection and COVID-vaccinations

TruDiagnostic1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2021年3月10日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
60
试验地点
1
主要终点
Methylation age clock testing

研究概览

简要总结

This is a retrospective non-randomized clinical study of 60 patients total to assess the effects of SARS-CoV-2 infection and the SARS-CoV-2 vaccination. This study will have 2 arms evaluating the epigenomes of patients pre and post-exposure to one of the interventions. The first arm of the study will analyze 40 patients' epigenomes whose DNA methylation was examined pre and post SARS-CoV-2 infection. The second arm of this study is analyzing 20 patients' epigenomes whose DNA methylation was examined pre and post-injection of the SARS-CoV-2 vaccine.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Subjects that are healthy individuals and of any sex, ethnicity, and anyone above the age of 18 years old.

排除标准

  • 未提供

结局指标

主要结局

Methylation age clock testing

时间窗: Change from baseline after COVID-19 mRNA vaccination

The DNA clocks that will be used to precisely measure aging is TruAge Biological Age test, which estimates biological age vs. chronological age

次要结局

  • Overall state of health(Change from baseline after COVID-19 mRNA vaccination)

研究者

发起方
TruDiagnostic
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验